Navigation Links
GlaxoSmithKline President of North America Pharmaceuticals, Deirdre Connelly, Named 2010 Woman of the Year by the Healthcare Businesswomen's Association
Date:2/16/2010

FAIRFIELD, N.J., Feb. 16 /PRNewswire-USNewswire/ -- The Healthcare Businesswomen's Association (HBA) today announced that its 2010 "Woman of the Year" is Deirdre P. Connelly, president of North America Pharmaceuticals for GlaxoSmithKline. Recognized for three consecutive years by Fortune magazine as one of the 50 most powerful women in business, Ms. Connelly is a respected leader in healthcare whose intense commitment to the patient has long driven her to foster innovation within the pharmaceutical industry.

"I am deeply honored to be named Woman of the Year by the Healthcare Businesswomen's Association," said Ms. Connelly. "I have not only been fortunate to have mentors throughout my own career, but have also experienced firsthand the HBA's commitment to develop and inspire female executives in healthcare."

Ms. Connelly will be honored at the HBA's 21st annual "Woman of the Year" (WOTY) Luncheon on Thursday, May 6, at the Hilton New York. This is the event of the year for the healthcare community attended by over 2,000 leaders in the industry. Awards for Honorable Mentor, the Star Volunteer, and a group of some 100 "Rising Stars," noted for their accomplishments and contributions to the healthcare industry, will also be presented at the luncheon.

While the HBA annually receives many compelling nominations for the WOTY award, the 2010 HBA nominating committee overwhelmingly agreed that Ms. Connelly's many accomplishments embodied the criteria for Woman of the Year, which includes success in the healthcare industry, strong leadership capabilities, proven mentoring skills, dedication, a commitment to giving back to women, and contributions to the community. Described by others as an approachable and engaged leader, Ms. Connelly is widely recognized by her colleagues as a passionate advocate for mentoring and continuous learning.

"The Healthcare Businesswomen's Association is extremely proud to honor Deirdre Connelly as our 2010 Woman of the Year, and we are inspired by her visionary capabilities in setting a clear path for success in a changing marketplace," said Susan Torroella, president of the Healthcare Businesswomen's Association and COO of MEDEX Global Group. "In addition to her numerous career accomplishments, Ms. Connelly's values of commitment to patients, integrity, transparency and respect are widely heralded among all who know her.  Women leaders like Ms. Connelly serve as role models for all women in the healthcare industry, demonstrating first-hand the contributions we can all make to society."  

Ms. Connelly joined GlaxoSmithKline in February 2009, where she leads an organization of approximately 10,000 employees and over $14 billion in sales. As part of her current responsibilities, she helps shape the future of the company as a member of its global corporate executive team and co-chairs its research portfolio management board. Prior to joining GlaxoSmithKline last year, Ms. Connelly spent 24 years with Eli Lilly and Company, where she most recently served as president of Lilly USA. She held a variety of executive positions at the company, including senior vice president of human resources for Eli Lilly and Company, vice president of human resources for pharmaceutical operations, executive director of global marketing for Evista, and leader of the U.S. women's health business unit. She began her career in the pharmaceutical industry in 1984 as a sales representative for Lilly in San Juan, Puerto Rico, where she was born.

"Deirdre has a deep commitment to the patient, the customer, and the values that are absolutely necessary for our future," said Andrew Witty, chief executive officer of GlaxoSmithKline. "The healthcare world is rapidly changing, and our industry will continue to operate effectively only if we gain society's trust. Since joining us, Deirdre has established a strong strategic vision for the U.S. market and has created a culture of performance while operating within a framework of integrity, respect and transparency. She not only talks about these values, she is a leader who lives these values and cultivates them in others."

In 2008, Ms. Connelly was appointed to the President's Commission on White House Fellowships, a prestigious program that grooms young professionals for work in public service.  She also serves as a member of the board of directors of Macy's Inc.

Ms. Connelly earned a bachelor's degree in economics and marketing from Lycoming College in Pennsylvania, and graduated from Harvard University's Advanced Management Program.  She has served as a mentor and leadership speaker for a number of organizations, including the HBA.

About The HBA

The Healthcare Businesswomen's Association (HBA; http://www.hbanet.org) is in its fourth decade as a global not-for-profit organization dedicated to furthering the advancement of women in healthcare worldwide.  With 14 chapters and affiliates throughout the U.S. and in Europe, the HBA is headquartered in New Jersey with offices in Philadelphia and Research Triangle Park.  The HBA provides educational opportunities for women and men to develop cutting-edge healthcare industry knowledge and leadership skills; recognizes outstanding women and men in the industry; provides opportunities for networking; creates greater visibility for women in the industry; fosters mentoring relationships and serves as a conduit and sponsor for research on career advancement issues.  HBA has over 5,000 individual members and over 120 Corporate Partners.  It is widely recognized as the catalyst for leadership development of women in healthcare worldwide. For more information, visit www.hbanet.org.

SOURCE Healthcare Businesswomen's Association (HBA)

RELATED LINKS
http://www.hbanet.org

'/>"/>

SOURCE Healthcare Businesswomen's Association (HBA)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
8. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
9. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
10. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
11. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):